Avadel Pharmaceuticals Plc (AVDL)
21.39
-0.09
(-0.42%)
USD |
NASDAQ |
Dec 11, 16:00
21.38
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Investing (Quarterly): -8.791M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alkermes Plc | -6.737M |
| Jazz Pharmaceuticals Plc | -327.80M |
| Medtronic Plc | -482.00M |
| STERIS Plc (Ireland) | -88.30M |
| Amarin Corp. Plc | -12.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 23.26M |
| Cash from Financing (Quarterly) | 2.635M |
| Free Cash Flow | 36.79M |
| Free Cash Flow Per Share (Quarterly) | 0.2296 |
| Free Cash Flow to Equity (Quarterly) | 23.91M |
| Free Cash Flow to Firm (Quarterly) | 24.14M |
| Free Cash Flow Yield | 1.75% |